National Research (NRC) Competitors $17.20 -0.56 (-3.15%) (As of 11:03 AM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends NRC vs. OABI, MXCT, ABSI, NOTV, LUNA, ONMD, BIAF, DKDCA, AIKI, and ISPCShould you be buying National Research stock or one of its competitors? The main competitors of National Research include OmniAb (OABI), MaxCyte (MXCT), Absci (ABSI), Inotiv (NOTV), Luna Innovations (LUNA), OneMedNet (ONMD), bioAffinity Technologies (BIAF), Data Knights Acquisition (DKDCA), AIkido Pharma (AIKI), and iSpecimen (ISPC). These companies are all part of the "commercial physical research" industry. National Research vs. OmniAb MaxCyte Absci Inotiv Luna Innovations OneMedNet bioAffinity Technologies Data Knights Acquisition AIkido Pharma iSpecimen OmniAb (NASDAQ:OABI) and National Research (NASDAQ:NRC) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their earnings, analyst recommendations, risk, institutional ownership, media sentiment, valuation, dividends, community ranking and profitability. Does the MarketBeat Community favor OABI or NRC? National Research received 88 more outperform votes than OmniAb when rated by MarketBeat users. However, 100.00% of users gave OmniAb an outperform vote while only 61.67% of users gave National Research an outperform vote. CompanyUnderperformOutperformOmniAbOutperform Votes23100.00% Underperform VotesNo VotesNational ResearchOutperform Votes11161.67% Underperform Votes6938.33% Which has more risk and volatility, OABI or NRC? OmniAb has a beta of -0.14, indicating that its share price is 114% less volatile than the S&P 500. Comparatively, National Research has a beta of 0.52, indicating that its share price is 48% less volatile than the S&P 500. Which has higher valuation and earnings, OABI or NRC? National Research has higher revenue and earnings than OmniAb. OmniAb is trading at a lower price-to-earnings ratio than National Research, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOmniAb$20.41M24.43-$50.62M-$0.62-5.69National Research$144.16M2.89$30.97M$1.1315.72 Do analysts recommend OABI or NRC? OmniAb currently has a consensus target price of $9.00, indicating a potential upside of 154.96%. Given OmniAb's stronger consensus rating and higher possible upside, analysts clearly believe OmniAb is more favorable than National Research.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score OmniAb 0 Sell rating(s) 0 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 3.00National Research 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do institutionals & insiders have more ownership in OABI or NRC? 72.1% of OmniAb shares are held by institutional investors. Comparatively, 47.3% of National Research shares are held by institutional investors. 8.6% of OmniAb shares are held by company insiders. Comparatively, 2.0% of National Research shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Is OABI or NRC more profitable? National Research has a net margin of 18.78% compared to OmniAb's net margin of -308.78%. National Research's return on equity of 67.40% beat OmniAb's return on equity.Company Net Margins Return on Equity Return on Assets OmniAb-308.78% -20.97% -18.05% National Research 18.78%67.40%21.92% Does the media favor OABI or NRC? In the previous week, National Research had 2 more articles in the media than OmniAb. MarketBeat recorded 3 mentions for National Research and 1 mentions for OmniAb. National Research's average media sentiment score of 0.18 beat OmniAb's score of -0.06 indicating that National Research is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OmniAb 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral National Research 0 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral SummaryNational Research beats OmniAb on 11 of the 18 factors compared between the two stocks. Ad WealthPress70%, 80%, 90% Win Rates? Grab Your Free Cheatsheets Today!Would you like to know the historic win rate of every trade you take before you place it? Well, it’s all possible with these FIVE Candlestick Pattern Cheatsheets.>> You can grab your FREE, laminated copies right here << Get National Research News Delivered to You Automatically Sign up to receive the latest news and ratings for NRC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NRC vs. The Competition Export to ExcelMetricNational ResearchCommercial physical research IndustryBusiness SectorNASDAQ ExchangeMarket Cap$416.93M$4.27B$7.30B$9.28BDividend Yield2.80%1.78%2.27%4.28%P/E Ratio15.7256.2228.2917.29Price / Sales2.8947.77411.31120.29Price / Cash11.6923.6231.4037.83Price / Book8.793.205.944.94Net Income$30.97M$139.50M$125.29M$225.76M7 Day Performance3.38%4.21%4.59%4.17%1 Month Performance-9.57%0.15%5.89%1.19%1 Year Performance-55.50%9.83%18.99%17.08% National Research Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NRCNational Research1.4345 of 5 stars$17.20-3.2%N/A-55.5%$403.79M$144.16M15.22435OABIOmniAb1.35 of 5 stars$3.49-0.3%$9.00+157.9%-39.1%$492.84M$20.41M-5.637MXCTMaxCyte2.9466 of 5 stars$4.04-4.7%$9.50+135.1%-10.3%$426.99M$45.60M-11.88143Gap DownABSIAbsci1.6625 of 5 stars$2.94-1.7%$8.67+194.8%-9.3%$337.68M$4.21M-3.16210Short Interest ↑NOTVInotiv3.074 of 5 stars$3.89-4.7%$5.92+52.1%+32.8%$101.20M$490.74M-0.932,075Options VolumeLUNALuna Innovations2.026 of 5 stars$1.60+6.3%$8.00+401.6%-77.2%$54.17M$116.61M-19.94337Analyst ForecastONMDOneMedNetN/A$1.33-5.0%N/A+35.3%$37.22M$1.14M0.002BIAFbioAffinity Technologies2.9991 of 5 stars$1.00+0.2%$6.00+503.0%-37.5%$15.51M$9.37M-1.2110News CoverageGap DownDKDCAData Knights AcquisitionN/A$1.40+33.3%N/A+35.3%$7.24MN/A-7.372Gap UpHigh Trading VolumeAIKIAIkido PharmaN/A$1.26-3.9%N/A-49.8%$6.91M$10,000.00-0.324ISPCiSpecimen0.283 of 5 stars$3.01+0.3%N/A+450.1%$2.90M$10.39M-0.1660Short Interest ↑ Related Companies and Tools Related Companies OABI Alternatives MXCT Alternatives ABSI Alternatives NOTV Alternatives LUNA Alternatives ONMD Alternatives BIAF Alternatives DKDCA Alternatives AIKI Alternatives ISPC Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:NRC) was last updated on 12/26/2024 by MarketBeat.com Staff From Our Partnersliberals FOOLED by Elon’s shocking surpriseElon Musk and Donald Trump fooled everyone. They said it was to “save free speech”... Or “fix what the l...StocksToTrade | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | SponsoredWARNING: “Buffett Indicator” flashing for first time in 50 yearsWarren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indi...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored“AI Killer” 10x More Powerful Than ChatGPTElon Musk may be about to “kill” the world’s most powerful AI. Very few people are talking about the one AI...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Research Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Research With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
